Methylin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7691880 SPECGX LLC Methylphenidate solution and associated methods of administration and production
Oct, 2024

(1 year, 7 days from now)

Methylin is owned by Specgx Llc.

Methylin contains Methylphenidate Hydrochloride.

Methylin has a total of 1 drug patent out of which 0 drug patents have expired.

Methylin was authorised for market use on 19 December, 2002.

Methylin is available in solution;oral dosage forms.

The generics of Methylin are possible to be released after 07 October, 2024.

Drugs and Companies using METHYLPHENIDATE HYDROCHLORIDE ingredient

Market Authorisation Date: 19 December, 2002

Treatment: NA


How can I launch a generic of METHYLIN before it's drug patent expiration?
More Information on Dosage

METHYLIN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic